References
- Marazziti D, Consoli G. Treatment strategies for obsessive-compulsive disorder. Expert Opin Pharmacother 2010;11(3):331–43. [CrossRef]
- Dell'Osso B, Mundo E, Marazziti D, et al. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series. Psychopharm 2008;22(2):210–3. [CrossRef]
- Williams HC, Dellavalle RP, Garner S. Acne vulgaris. The Lancet 2012;379(9813):361–72. [CrossRef]
- Grupper C. New iatrogenic acne: acne caused by amineptine (Survector). Ann Dermatol Venereol 1988;115(11):1174–6.
- Lévigne V, Faisant M, Mourier C, et al. Monstrous acne in the adult. Inducer role of Survector? Ann Dermatol Venereol 1988;115(11):1184–5.
- Teillac D, Weber MJ, Lowenstein W, et al. Acne cause by Survector. Ann Dermatol Venereol 1988;115(11):1183–4.
- Thioly-Bensoussan D, Charpentier A, Triller R, et al. Iatrogenic acne caused by amineptin (Survector). Apropos of 8 cases. Ann Dermatol Venereol 1988;115(11):1177–80.
- Vexiau P, Gourmel B, Husson C, et al. Severe lesions of acne type induced by chronic amineptine poisoning: apropos of 6 cases. Ann Dermatol Venereol 1988;115(11):1180–2.
- Vexiau P, Gourmel B, Castot A, et al. Severe acne due to chronic amineptine overdose. Arch Dermatol Res 1990;282(2):103–7. [CrossRef]
- Perahia DGS, Wang F, Mallinckrodt CH, et al. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Psychiatry 2006;21:367–78. [CrossRef]
- Khan AY, Macaluso M. Duloxetine for the treatment of generalized anxiety disorder: a review. Neuropsychiatr Dis Treat 2009;5:23–31.
- Brannan SK, Mallinckrodt CH, Brown EB, et al. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J of Psychiatr Res 2005;39:43–53. [CrossRef]
- Knadler MP, Lobo E, Chappell J, et al. Duloxetine clinical pharmacokinetics and drug interactions. Clin Pharmacokinet 2011; 50(5):281–94. [CrossRef]
- Eli Lilly and Company. Highlights of prescribing information, November 2012 (available at http://pi.lilly.com/us/cymbalta-pi.pdf, accessed November 1, 2013).